Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The city on Wednesday will officially launch what it is calling a “neighborhood wellness court” in Kensington, an initiative ...